Sage Journals: Discover world-class research

Abstract

Prior to transplantation into individuals with type 1 diabetes, in vitro assays are used to evaluate the quality, function and survival of isolated human islets. In addition to the assessments of these parameters in islet, they can be evaluated by multiparametric morphological scoring (0–10 points) and grading (A, B, C, D, and F) based on islet characteristics (shape, border, integrity, single cells, and diameter). However, correlation between the multiparametric assessment and transplantation outcome has not been fully elucidated. In this study, 55 human islet isolations were scored using this multiparametric assessment. The results were correlated with outcomes after transplantation into immunodeficient diabetic mice. In addition, the multiparametric assessment was compared with oxygen consumption rate of isolated islets as a potential prediction factor for successful transplantations. All islet batches were assessed and found to score: 9 points (n = 18, Grade A), 8 points (n = 19, Grade B), and 7 points (n = 18, Grade B). Islets that scored 9 (Grade A), scored 8 (Grade B) and scored 7 (Grade B) were transplanted into NOD/SCID mice and reversed diabetes in 81.2%, 59.4%, and 33.3% of animals, respectively (P < 0.0001). Islet scoring and grading correlated well with glycemic control post-transplantation (P < 0.0001) and reversal rate of diabetes (P < 0.05). Notably, islet scoring and grading showed stronger correlation with transplantation outcome compared to oxygen consumption rate. Taken together, a multiparametric assessment of isolated human islets was highly predictive of transplantation outcome in diabetic mice.

Keywords

type 1 diabetes islet transplantation morphological score morphological grade;human islets;immunodeficient diabetic mouse

Introduction

Type 1 diabetes (T1D) is an autoimmune disease that results from the destruction of insulin-producing pancreatic islet β-cells. The majority of T1D individuals depend on insulin replacement to provide glucose homeostasis. However, in T1D, blood glucose control within a physiological range is not easily achieved, and uncontrolled hyperglycemia degrades the function of multiple organs including the heart, vasculature, kidneys and eyes^1,2. Further, despite glycemic control with insulin, some T1D individuals experience life-threatening hypoglycemia and hypoglycemia unawareness. Islet transplantation (IT) provides insulin independence and mitigates life-threatening hypoglycemia unawareness and organ damage in T1D^3
–5. Several factors influence the quality of isolated islets and subsequent islet transplantation outcomes. Donor characteristics including sex, body mass index, and age, as well as technical details of the isolation process, impact islet quality and outcomes following IT^6

–9.

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)-funded Clinical Islet Transplantation Consortium released detailed standards for determining isolated islet quality that take into account islet equivalent (IEQ), purity, viability, and glucose-stimulated insulin secretion (GSIS)^10
–12. While providing release criteria metrics, these assays do not predict IT outcomes well, except IEQs transplanted¹³. Recently, analyses of islet oxygen consumption rate (OCR) were reported to predict IT outcomes. OCR normalized to DNA content (OCR/DNA) and increment of OCR stimulated by the glucose predict IT outcomes in rodents^14
–16, and OCR dose, the product of islet dose and OCR/DNA, predicts clinical allo- and auto-IT outcomes^17,18. We developed a computer-based semi-automated viability assessment tool as an alternative to conventional manual viability assessment¹⁹. Other methods such as islet cellular composition assessment using laser scanning cytometry and the ADP/ATP ratio of isolated islets can assist in grading the quality of isolated islets^20,21. Regardless of the assay employed, timely evaluation of islet quality is paramount. Unfortunately, current in vitro assays of isolated islet quality and function are time consuming. Thus, there remains a need for islet assessment tools that require little time and yet accurately predict IT outcomes. Herein, we tested a multiparametric assessment including islet morphological scoring (0–10 points) and grading (A, B, C, D, and F) based on the islet characteristics (shape, border, integrity, single cells, and diameter) to predict islet function after transplantation in immunodeficient diabetic mice.

Materials and Methods

Study Design

This study retrospectively determined the correlation between a multiparametric assessment of isolated islets prior to transplantation (n = 55, period of islet isolation: March 2015 – June 2018) and outcome of islet graft function following transplantation into immunodeficient diabetic mice. The parameters were also compared with OCR (n = 49).

Human Donor Pancreata for Islet Isolation

Human pancreata from deceased donors were obtained from a local organ procurement organization (OneLegacy, Los Angeles, CA, USA) for islet isolation. The pancreata were stored on ice in cold preservation solution (University of Wisconsin solution or histidine-tryptophan-ketoglutarate solution) and transported to the current Good Manufacturing Practices facility at City of Hope. All pancreata processed in this study were approved for research by the Institutional Research Board of City of Hope (IRB # 01046) and informed consent was obtained from family or relatives of the donors.

Isolation of Human Islets

Islet isolations were conducted as described²². Briefly, the pancreas was trimmed of fat and connective tissue before perfusion with a collagenase/protease solution through the main pancreatic duct using an automatic perfusion apparatus (Biorep Technologies, Miami Lakes, FL, USA). The pancreas was then cut into 7–12 pieces and further digested in a Ricordi digestion chamber at 37°C²³. Isolated islets were purified with continuous density gradient centrifugation using a COBE 2991 cell processor system (Terumo BCT, Lakewood, CO, USA)²⁴. Islet fractions were pooled according to purity as determined by Dithizone (DTZ) staining (iDTZ, Gemini Bio-products, CA, USA)²⁵. Islet particulate number (IPN) was determined, and total islet counts were then converted into islet equivalent (IEQ) which represent islets of 150 µm diameter IEQ²⁶. Islet morphological scoring was performed followed by culture at 37°C with 5% CO₂ and subsequent analyses.

Islet Multiparametric Assessment

Scoring of DTZ-stained islets was completed on the day of isolation using a bright-field microscope (CKX31, Olympus, Tokyo, Japan) and a 4× objective lens. Details of the five scored parameters (shape, border, integrity, single cells, and diameter) are found in Table 1 ¹². Each individual parameter was scored from 0–2 points, and the total score was calculated. The total scores were then categorized as A (best), B, C, D, and F (worst). Islet assessment was performed for the available islet fractions, as defined by the purity of each batch (fraction 1, ≥70% pure; fraction 2, 40–70% pure, and fraction 3, ≤40% pure).

Table 1.

Islet Morphological Score and Grade.

Islet Morphological Score
Parameter	Score	Description
Shape (three-dimensional)	0	Flat/planer
	1	In between
	2	Spherical
Border (two-dimensional)	0	Irregular
	1	In between
	2	Well-rounded
Integrity	0	Fragmented
	1	In between
	2	Solid/compact
Single cells	0	Many
	1	A few
	2	Almost none
Diameter	0	All islets <100 µm
	1	Less than 10% of islets > 200 µm
	2	>10% of islets >200 µm
Islet Morphological Grade	Description
A	Total score: 9–10 points
B	Total score: 7–8 points
C	Total score: 4–6 points
D	Total score: 2–3 points
F	Total score: 0–1 points

Metabolic Assessment of Isolated Islets

The oxygen consumption rate (OCR) of isolated islets was measured using a Seahorse XFe24 analyzer (Agilent, Santa Clara, CA, USA)^27,28. Briefly, islets (70–100 IEQ) were plated into 4 or more separate wells of a Seahorse XFe islet capture plate. The islet OCR was measured at base line (3 mM glucose for 45 minutes), after glucose stimulation (20 mM glucose for 53 minutes) and during inhibition of mitochondrial respiration (5 nM oligomycin for 105 minutes). Measurements were repeated every 7.5 minutes until the end of the experiment. The basal OCR (OCR basal) was calculated as the average OCR obtained on incubation in 3 mM glucose solution. The maximum OCR was obtained at least 1 hour after the initiation of glucose stimulation. The OCR fold increase was defined as the maximum OCR/basal OCR (OCR_SI).

Human Islet Transplantation Into Diabetic Immunodeficient Mice

Animal studies were approved by the City of Hope Beckman Research Institute Institutional Animal Care and Use Committee. Male 8–12 week-old non-obese diabetic, severe combined immunodeficiency (NOD/SCID) mice (Charles River Laboratories, Wilmington, MA, USA) were used as recipients for islet transplantations as described^19,28. Mice were rendered diabetic by intraperitoneal injections of 50 mg/kg of streptozotocin (Sigma-Aldrich, St. Louis, MO, USA) for three consecutive days. Mice with a blood glucose level >350 mg/dL underwent IT and blood glucose levels were monitored twice a week. Diabetes reversal was defined as a blood glucose <200 mg/dL on at least three consecutive measurements. A total of 202 mice were transplanted with isolated human islets from 55 separate isolations (donors). For each islet isolation, 1–8 mice were transplanted with 1200 IEQ under the left kidney capsule^28,30. For quantitative evaluation of post-transplant blood glucose control in individual mice, the area under the curve (AUC) of blood glucose from days 0–28 (AUC_0-28) was determined¹⁹. These quantitative parameters correlated well with diabetes reversal (Supplemental Fig. S1A). AUC also correlated with the number of days to reverse diabetes in the mice that achieved a blood glucose <200 mg/dL (Supplemental Fig. S1B). As well, the diabetes reversal rate for each islet batch, defined as the number of mice with diabetes reversal/number of mice transplanted, was determined. Five islet isolation batches were excluded from the analysis since in these instances only 1 or 2 mice were transplanted.

Statistical Analysis

Comparisons between two factors were analyzed using the Student’s t-test. Multivariate analysis was performed to identify the statistical correlations between several variables (Pearson’s correlation). Receiver operating characteristic (ROC) curves were used to calculate the optimal cutoff value to distinguish two groups among the data set. The comparisons between two groups in the cumulative diabetes reversal assessment were analyzed using a log-rank test. All statistical analyses were performed using JMP 9.0.0 software (SAS Institute, Cary, NC, USA). A P < 0.05 was considered significant.

Results

Islet Characteristics and Morphological Scoring

Donor information and islet characteristics are shown in Table 2. All 55 islet preparations scored either 1 or 2 points for all parameters (Fig. 1). The distribution of the scores for each parameter is shown in Fig. 2A. Most islet isolation batches scored 2 points for all parameters except for islet integrity. The cumulative islet morphological score ranged between 7 and 9 points (full score = 10 points), with an average of 8.0 ± 0.1 points (Fig 2B). Islet isolation batches evenly distributed into each total score: 18 batches for 7 points, 19 batches for 8 points, and 18 batches for 9 points. Based on the grading shown in Table 1, 18 batches fell into Grade A (9–10 points) and 37 batches Grade B (7–8 points). These data confirmed that our standard operating procedure for pancreatic islet isolation delivered morphologically high-quality islets.

Table 2.

Donor and Islet Characteristics.

	Average ± SEM	Range (Minimum–Maximum)	Observations (n)	Note
Donor factors
HbA1c (%)	5.8 ± 0.2	4.6–14.7	55
Age (yrs)	46 ± 1.6	17–64	55
Sex	n/a	n/a	55	Male = 42, Female = 13
BMI (kg/m²)	30.1 ± 1.0	21.4–63.1	55
Isolation factors
Cold ischemia time (h)	6.6 ± 0.3	3–12	55
Post-isolation_IEQ	264,323 ± 21,900	48,900–659,249	55
Post-isolation_IPN	259,431 ± 20,696	31,000–798,500	55
IEQ/IPN	1.1 ± 0.1	0.5–3.1	55
Post-isolation assessments
Islet morphological score	8.0 ± 0.1	7–9	55	Post-isolation assessment; Manual counting; details in Fig. 1
Islet morphological grade	n/a	A–B	55	Post-isolation assessment; Grade A = 18; B = 37; C–F = 0; details Table 1
Viability (manual assessment) (%)	96.0 ± 0.3	88–99	55	Manual counting
Viability (semi-automated assessment)	94.3 ± 1.0	63.5–99.9	55	Semi-automated counting
OCR_SI	1.43 ± 0.02	1.18–1.88	49	Used for comparison to islet morphological score/grade in this study
GSIS-SI (static incubation)	2.2 ± 0.2	0.7–6.9	53
Purity (%)	78.7 ± 0.9	63–95	54	Manual counting
Days in culture	2.6 ± 0.2	0–9	55	Days between isolation and transplantation

Abbreviations: SEM, standard error of the mean; HbA1c, hemoglobin A1c; BMI, body mass index; GSIS, glucose-stimulated insulin secretion; IEQ, islet equivalent; IPN, islet particle number; OCR, oxygen consumption rate; SI, stimulation index

Figure 1.

Representative images of isolated human islets displaying typical morphologic features. Images are from the dataset of the current study. Islets were scored for shape (three-dimensional), border (two-dimensional), integrity, single cells, and diameter. Each individual parameter was scored from 0 to 2 point(s). No islets scored 0 in any parameter. Islets were stained with iDTZ solution. Scale bar, 100 μm. See Table 1 for additional details.

Figure 2.

Distribution of islet morphological scores and grades. (A) Distribution of the scores of individual parameters (n = 55 islet batches in each parameter). (B) Distribution of the total scores and grades (n = 55 islet batches).

Islet Morphological Score Strongly Correlates with in vivo Islet Transplantation Outcomes

The results of human islet transplantation in mice are summarized in Table 3. We analyzed the correlations between islet assessment data and transplantation outcomes. The AUC_0-28 was used to quantify transplantation outcome in individual mice while the diabetes reversal rate of each islet batch was taken as an indicators of post-transplant glycemic control. Interestingly, islet morphological score was highly and inversely correlated to transplantation outcomes (r = −0.4048, P < 0.0001) (Table 4). Notably, it showed stronger correlation to the AUC_0-28 as compared to OCR_SI (r = −0.282, p = 0.0001) and semi-automated viability (r = −0.204, p = 0.0039). As well, the islet morphological score was the only variable that significantly and positively correlated with the diabetes reversal rate (r = 0.2876, p = 0.0428).

Table 3.

Characteristics of Mouse Transplantation Data.

Mouse data	Ave ± SEM	Range (Minimum–Maximum)	Observations (n)	Note
Total transplantations	n/a	n/a	202	Total number of mouse recipients
Mouse # per islet batch	4.1 ± 0.1	1–8	55	Fifty-five isolations
Observation period (days)	39.5 ± 0.9	20–94	202
Diabetes reversal rate (%)	52.4 ± 6.1	0-100	50	Five isolations excluded with <3 mice transplantations
Days until diabetes reversal	12.3 ± 0.6	2–32	118	Calculated among diabetes reversed cases
Blood glucose control (AUC_0-28; mg/dL*days)	8,363 ± 337	2,325–16,693	202	Details of AUC_0-28 in Supplemental Fig. S1

Abbreviations: SEM, standard error of the mean; AUC, area under curve

Table 4.

Post-Isolation Assessments with Significant Correlations to Transplantation Outcomes.

Assessments	Correlation (r)	P-value
Correlation to AUC_0-28
Morphological Score	−0.4048	<0.0001
OCR_SI	−0.282	0.0001
Semi-automated Viability	−0.204	0.0039
% of islets (>250 µm diameter)	0.1942	0.0061
Purity	−0.1749	0.013
Correlation to Reversal rate
Morphological Score	0.2876	0.0428

Abbreviations: AUC, area under curve; OCR, oxygen consumption rate; SI, stimulation index

We further investigated if transplantation outcomes varied in relation to islet morphologic score. We found that islet morphological scores significantly impacted the post-transplant glycemic control as measured by AUC_0-28 (Fig. 3A). Indeed, diabetes reversal rates tracked quite closely with islet morphological scores (Fig. 3B, P < 0.0001). Mice that received islets that were scored 9, 8, and 7, showed reversal of diabetes in 81.2%, 59.4%, and 33.3% of animals, respectively.

Figure 3.

Islet morphological scores positively correlate with islet transplantation outcomes. (A) Correlation of islet morphological scores (7–9 points) to AUC_0-28; n = 62 mice transplanted with islets graded 7 points, n = 70 mice transplanted with islets graded 8 points, and n = 70 mice transplanted with islets graded 9 points. (B) Cumulative curves of diabetes reversal derived from blood glucose levels from diabetic animals transplanted with islets from the indicated scored islet groups. ** P < 0.01, **** P < 0.0001. Student’s t-test and Log-Rank test (Prob>ChiSq) were used to determine significance in Fig. 3A, B, respectively.

Islet Morphological Grade is Comparable to Metabolic Assessment (OCR) as a Predictor of Transplantation Outcome

We compared the potential of islet morphological grade and metabolic assessment (OCR) to predict transplantation outcome. Data from each assay were categorized into two groups: Grade A (score 9–10) or B (score 7–8) for islet morphological grade; <1.24 or >1.24 for OCR-SI. Using a ROC curve, 1.24 was selected as an optimal cutoff for OCR-SI (Supplemental Fig. S2). Mice that received islets graded A, and >1.24 in OCR-SI demonstrated significantly better glycemic control, as defined by lower AUC_0-28 values, when compared to other groups (P < 0.0001 in morphological grade B, Fig. 4A; P < 0.0001 in OCR-SI<1.24, Fig. 4B). Mice that received Grade A islets showed reversal of diabetes in 81.2% of animals, whereas those received Grade B islets showed reversal in 46.6% of animals (Fig. 4C, P < 0.0001). Mice that received islets of OCR_SI >1.24 showed diabetes reversal in 66.0% of animals, whereas those received islets of OCR_SI <1.24 showed reversal in 22.3% (Fig. 4D, p = 0.0001). Both islet assessment methods predicted islet transplantation outcome but vary in their sensitivity and specificity (Table 5).

Figure 4.

Islet morphological grade is effective at predicating islet transplantation outcome compared to OCR. (A) Correlation of islet morphological grade (Grade A vs. Grade B) to AUC_0-28; n = 70 mice transplanted with Grade A and n = 132 mice transplanted in Grade B islets. (B) Correlation of OCR-SI (<1.24 vs. >1.24) to AUC_0-28; n = 36 mice transplanted with islets having an OCR <1.24 and n = 145 mice transplanted with islets having an OCR >1.24. (C) Cumulative curves of diabetes reversal according to the morphological grade. (D) Cumulative curves of diabetes reversal according to the OCR-SI. *** P < 0.001, **** P < 0.0001. Student-t test and Log-Rank test (Prob>ChiSq) were used to calculate significance in Figures 4A, B, and Figures 4C, D, respectively.

Table 5.

Sensitivity and Specificity of Pre-Transplant Assessments to Predict Islet Transplantation Outcome.

	Islet morphological grade (A vs. B)	OCR (cutoff = 1.24)
Sensitivity (true positive rate)	81.2%	66.0%
Specificity (true negative rate)	53.4%	77.1%

Abbreviation: OCR, oxygen consumption rate.

Individual Parameters in Islet Evaluation Correlate with Transplantation Outcome

Total islet score and grade predicted islet transplant outcomes. However, it was not clear if one or more parameters more closely tracked with outcome. We analyzed transplantation outcome (AUC_0-28) in relation to the score of each parameter (Fig 5). A high score (2 points) in three parameters (border, integrity, and single cells) individually correlated with better post-transplant glycemic control when compared to a low score (1 point) (p = 0.0213, p = 0.0225, and p = 0.0001, respectively). The interaction analysis of the five parameters revealed that each parameter was relatively independent (Supplemental Fig. S3).

Figure 5.

Individual parameters in the islet morphological score positively correlate with transplantation outcome. Post-transplant glycemic control values of mice (AUC_0-28) were plotted according to the individual parameters (shape, border, integrity, single cells, and diameter). Boxplots demonstrate data distribution, interquartile range, and median. The Student’s t-test was used to determine significance. *P < 0.05, ***P < 0.001.

Discussion

In this study, a multiparameter islet assessment based on shape, border, integrity, single cells, and diameter was found to significantly correlate with islet transplant outcomes in immunodeficient diabetic mice. Accordingly, the multiparametric islet assessment showed advantage over other assays including stimulation index in OCR assay and semi-automated viability for assessing islet transplantation outcomes. The multiparametric assessment requires only DTZ staining of islets³¹ and should be performed immediately after islet isolation using light microscopy²⁵. As the technical requirements for morphologic assessment are modest, this method can be applied widely. Five parameters were used to score the islets (shape, border, integrity, single cells and diameter) with points assigned from 0 to 2. The narrow range of scoring may limit the consideration of subtle differences in islet morphology but has the advantage of being easier to master and implement. It should be pointed out that scoring reflects certain unique aspects derived from our experience. This is exemplified in the score we assigned to islet size. Indeed, other data suggested that islet size might not reflect transplant outcome³². Islets were then further categorized into several grades (A, B, C, D, and F) based on the total score for overall islet quality and integrity. Counting of DTZ-stained islets is a gold standard for calculating islet particle number (IPN) and to determine the final islet equivalent (IEQ)³³. The islet scoring system employed in the present study uses the well-established methods of DTZ staining and observation under light microscopy. And, while being somewhat operator-dependent, morphologic scoring was found superior in certain aspects compared to the stimulation index in OCR assay and semi-automated viability. There are several potential reasons for this. First, all scored parameters showed the same trend in relation to islet transplant outcome, that is the higher score in any parameter positively correlated with better post-transplantation glucose control. Second, as demonstrated in the interaction analysis, each of the five scored parameters were relatively independent of the other. Therefore, adding together the score of each individual parameter acted to enhance the predictive value of the combined score.

Islet transplantation is largely restricted to centers with substantial experience in isolating human islets for clinical and research applications. Characterization of islets is essential and performed immediately after isolation. Consistent with this, in the present analysis, among the 55 islet batches scored, the average scores assigned by the two study investigators were 8.03 ± 0.16 (range: 7–9) versus 7.96 ± 0.16 (range: 7–9). The distribution of the scores by each investigator were also similar. These results indicate that islet assessments are reproducible between individuals. Expanding upon this, the data generated from this multiparametric assessment could aid in developing computer-based automated platforms for morphometric assessment^34

–37. For instance, shape and border may be digitally evaluated using the shape factor, a numerical factor describing the shape of a particle of two-dimensional images^38,39. Single cells and islet diameter could be detected by computer-based image analysis to further improve objectivity^19,29.

Uniformity in islet characterization for clinical transplantation is needed for rationale interpretation of outcomes that then inform therapeutic decisions. Wider utilization of this approach and sharing of data may permit refinements such as development of automated non-biased assessment software tools. In regard to the clinical application, Grade A and B islets are designated as transplant-quality islets especially if the islet yield/volume of fraction 1 are high, islet recovery is more than 30% post-culture, and donor age is less than 50 years old. It is worth noting that Grade B islets have also been used in clinical transplantation and are administered particularly for 2nd or 3rd infusion^4,40,41. In this study, fraction 1 was used to assess islet quality. However, the multiparameter assay performed for islets from fraction 2 or 3 often found identical to those of fraction 1. It is important to point out that establishing a multiparametric assessment and biomimetic potency tests would assist in the effort to obtain a biological license for IT from the US Food and Drug Administration^41

–44.

In conclusion, multiparametric assessment of isolated human islets highly predicted transplantation outcomes in diabetic mice. In this regard, multiparametric assessment compared favorably to other more costly and time-consuming techniques of islet evaluation. Application of multiparametric assessment of islets to transplant quality and research grade islets could improve clinical islet transplant outcomes and decrease the heterogeneity of research results.

Supplemental Material

Supplemental Material, sj-jpg-1-cll-10.1177_09636897211052291 - A Multiparametric Assessment of Human Islets Predicts Transplant Outcomes in Diabetic Mice

Supplemental Material, sj-jpg-1-cll-10.1177_09636897211052291 for A Multiparametric Assessment of Human Islets Predicts Transplant Outcomes in Diabetic Mice by Hirotake Komatsu, Meirigeng Qi, Nelson Gonzalez, Mayra Salgado, Leonard Medrano, Jeffrey Rawson, Chris Orr, Keiko Omori, Jeffrey S. Isenberg, Fouad Kandeel, Yoko Mullen and Ismail H. Al-Abdullah in Cell Transplantation

Supplemental Material

Supplemental Material, sj-jpg-2-cll-10.1177_09636897211052291 - A Multiparametric Assessment of Human Islets Predicts Transplant Outcomes in Diabetic Mice

Supplemental Material, sj-jpg-2-cll-10.1177_09636897211052291 for A Multiparametric Assessment of Human Islets Predicts Transplant Outcomes in Diabetic Mice by Hirotake Komatsu, Meirigeng Qi, Nelson Gonzalez, Mayra Salgado, Leonard Medrano, Jeffrey Rawson, Chris Orr, Keiko Omori, Jeffrey S. Isenberg, Fouad Kandeel, Yoko Mullen and Ismail H. Al-Abdullah in Cell Transplantation

Supplemental Material

Supplemental Material, sj-jpg-3-cll-10.1177_09636897211052291 - A Multiparametric Assessment of Human Islets Predicts Transplant Outcomes in Diabetic Mice

Supplemental Material, sj-jpg-3-cll-10.1177_09636897211052291 for A Multiparametric Assessment of Human Islets Predicts Transplant Outcomes in Diabetic Mice by Hirotake Komatsu, Meirigeng Qi, Nelson Gonzalez, Mayra Salgado, Leonard Medrano, Jeffrey Rawson, Chris Orr, Keiko Omori, Jeffrey S. Isenberg, Fouad Kandeel, Yoko Mullen and Ismail H. Al-Abdullah in Cell Transplantation

Footnotes

Acknowledgments

We thank Sung Hee Kil, Ph.D., for critical reading and editing of the manuscript; and Taro Yoshida for figure production.

Authorship

H.K. designed the study. H.K., M.Q., and I.H.A. wrote the manuscript. H.K., M.Q., I.H.A., N.G., M.S., L.M, J.R., C.O., K.O. collected and analyzed data. J.S.I, F.K. and Y.M. provided scientific feedback, and reviewed and edited the manuscript.

Disclosure

All authors certify that there are no conflicts of interest with any financial organization regarding the material discussed in the manuscript.

Ethical Approval

This study was approved by the institutional review board of Beckman Research Institute, City of Hope.

Statement of Human and Animal rights

All of the experimental animal procedures in this study were conducted in accordance with the Institutional Animal Care and Use Committee of Beckman Research Institute, City of Hope.

Statement of Informed Consent

Human islets were isolated from the human pancreata of deceased donors with informed research consent in place.

Data availability statement

The data that support the findings of this study are available to researchers upon request.

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) diclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The financial support was provided by the Nora Eccles Treadwell Foundation (Grant Period: July 1, 2012–June 30, 2020, P.I.: Yoko Mullen, M.D., Ph.D.; July 1, 2020–June 30, 2024, P.I.: Hirotake Komatsu, M.D., Ph.D.).

ORCID iDs

Hirotake Komatsu, MD, PhD

Jeffrey S. Isenberg, MD, MPH

Supplemental Material

Supplemental material for this article is available online.

References

The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes. 1986;35(5):530–545.

Diabetes Control and Complications Trial Research Group; Nathan

Genuth

Lachin

Cleary

Crofford

Davis

Rand

Siebert

. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986.

Foster

Bridges

Feurer

Eggerman

Hunsicker

Alejandro

; Clinical Islet Transplantation Consortium. Improved health-related quality of life in a phase 3 islet transplantation trial in type 1 diabetes complicated by severe hypoglycemia. Diabetes Care. 2018;41(5):1001–1008.

Shapiro

Lakey

Ryan

Korbutt

Toth

Warnock

Kneteman

Rajotte

. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343(4):230–238.

Shapiro

Pokrywczynska

Ricordi

. Clinical pancreatic islet transplantation. Nat Rev Endocrinol. 2017;13(5):268–277.

Hanley

Paraskevas

Rosenberg

. Donor and isolation variables predicting human islet isolation success. Transplantation. 2008;85(7):950–955.

O’Gorman

Kin

Murdoch

Richer

McGhee-Wilson

Ryan

Shapiro

Lakey

. The standardization of pancreatic donors for islet isolations. Transplantation. 2005;80(6):801–806.

Valiente

McFadden

Omori

Bilbao

Juan

Rawson

Scott

Ferreri

Mullen

El-Shahawy

, et al. The choice of enzyme for human pancreas digestion is a critical factor for increasing the success of islet isolation. Transplant Direct. 2015;1(4):e14.

Zeng

Torre

Karrison

Thistlethwaite

. The correlation between donor characteristics and the success of human islet isolation. Transplantation. 1994;57(6):954–958.

10.

NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee; NIH CIT Consortium. Purified Human Pancreatic Islet - Viability Estimation of Islet Using Fluorescent Dyes (FDA/PI): Standard operating procedure of the NIH clinical Islet transplantation consortium. CellR4 Repair Replace Regen Reprogram. 2015;3(1):e1378.

11.

NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee; NIH CIT Consortium. Purified Human Pancreatic Islet: Qualitative and quantitative assessment of islets using dithizone (DTZ): standard operating procedure of the NIH clinical islet transplantation consortium. CellR4 Repair Replace Regen Reprogram. 2015;3(1):e1369.

12.

NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee; NIH CIT Consortium. Purified human pancreatic islets master production batch record, Part 1 University of Illinois, Chicago & University of Miami (Product Codes PHPI-A-01 & PHPI-L-01). CellR4 Repair Replace Regen Reprogram. 2017;5(2):e2284.

13.

Balamurugan

Naziruddin

Lockridge

Tiwari

Loganathan

Takita

Matsumoto

Papas

Trieger

Rainis

Kin

, et al. Islet product characteristics and factors related to successful human islet transplantation from the Collaborative Islet Transplant Registry (CITR) 1999–2010. Am J Transplant. 2014;14(11):2595–2606.

14.

Papas

Colton

Nelson

Rozak

Avgoustiniatos

Scott

3rd Wildey

Pisania

Weir

Hering

. Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice. Am J Transplant. 2007;7(3):707–713.

15.

Sweet

Gilbert

Jensen

Sabek

Fraga

Gaber

Reems

. Glucose stimulation of cytochrome C reduction and oxygen consumption as assessment of human islet quality. Transplantation. 2005;80(8):1003–1011.

16.

Sweet

Gilbert

Scott

Todorov

Jensen

Nair

Al-Abdullah

Rawson

Kandeel

Ferreri

. Glucose-stimulated increment in oxygen consumption rate as a standardized test of human islet quality. Am J Transplant. 2008;8(1):183–192.

17.

Kitzmann

O’Gorman

Kin

Gruessner

Senior

Imes

Gruessner

Shapiro

Papas

. Islet oxygen consumption rate dose predicts insulin independence for first clinical islet allotransplants. Transplant Proc. 2014;46(6):1985–1988.

18.

Papas

Bellin

Sutherland

Suszynski

Kitzmann

Avgoustiniatos

Gruessner

Mueller

Beilman

Balamurugan

Loganathan

, et al. Islet oxygen consumption rate (OCR) dose predicts insulin independence in clinical islet autotransplantation. PLoS One. 2015;10(8):e0134428.

19.

Salgado

Gonzalez

Medrano

Rawson

Omori

Al-Abdullah

Kandeel

Mullen

Komatsu

. Semi-automated assessment of human islet viability predicts transplantation outcomes in a diabetic mouse model. Cell Transplant. 2020;29:963689720919444.

20.

Goto

Holgersson

Kumagai-Braesch

Korsgren

. The ADP/ATP ratio: a novel predictive assay for quality assessment of isolated pancreatic islets. Am J Transplant. 2006;6(10):2483–2487.

21.

Ichii

Inverardi

Pileggi

Molano

Cabrera

Caicedo

Messinger

Kuroda

Berggren

Ricordi

. A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant. 2005;5(7):1635–1645.

22.

Luis

Bilbao

Omori

Rawson

McFadden

Juan

Nair

Mullen

El-Shahawy

Dafoe

, et al. Sodium levels of human pancreatic donors are a critical factor for determination of islet efficacy and survival. Am J Physiol Endocrinol Metab. 2015;308(5): E362–E369.

23.

Ricordi

Goldstein

Balamurugan

Szot

Kin

Liu

Czarniecki

Barbaro

Bridges

Cano

Clarke

, et al. National institutes of health-sponsored clinical islet transplantation consortium phase 3 trial: manufacture of a complex cellular product at eight processing facilities. Diabetes. 2016;65(11):3418–3428.

24.

Friberg

Stahle

Brandhorst

Korsgren

Brandhorst

. Human islet separation utilizing a closed automated purification system. Cell Transplant. 2008;17(12):1305–1313.

25.

Khiatah

Chen

Perez

Valiente

Omori

Isenberg

Kandeel

Yee

Al-Abdullah

. Pancreatic human islets and insulin-producing cells derived from embryonic stem cells are rapidly identified by a newly developed Dithizone. Sci Rep. 2019;9(1):9295.

26.

Ricordi

. Quantitative and qualitative standards for islet isolation assessment in humans and large mammals. Pancreas. 1991;6(2):242–244.

27.

Komatsu

Kang

Medrano

Barriga

Mendez

Rawson

Omori

Ferreri

Tai

Kandeel

Mullen

. Isolated human islets require hyperoxia to maintain islet mass, metabolism, and function. Biochem Biophys Res Commun. 2016;470(3):534–538.

28.

Komatsu

Rawson

Medrano

Cook

Barriga

Gonzalez

Salgado

Omori

Kandeel

Tai

Mullen

. Optimizing temperature and oxygen supports long-term culture of human islets. Transplantation. 2019;103(2):299–306.

29.

Komatsu

Salgado

Gonzalez

Medrano

Rawson

Omori

Al-Abdullah

Kandeel

Mullen

. High fractions of large islets in human islet preparations detrimentally affect posttransplant outcomes in streptozotocin-induced diabetic immunodeficient mice. Pancreas. 2020;49(5):650–654.

30.

McFadden

Valiente

Omori

Bilbao

Juan

Rawson

Oancea

Scott

Nair

Ferreri

, et al. Human pancreatic islets isolated from donors with elevated HbA1c levels: islet yield and graft efficacy. Cell Transplant. 2015;24(9):1879–1886.

31.

Latif

Noel

Alejandro

. A simple method of staining fresh and cultured islets. Transplantation. 1988;45(4):827–830.

32.

Hughes

Bateman

Cross

Brandhorst

Spiliotis

Ballav

Rosenthal

Rutter

Shaw

Gough

, et al.

Does islet size really influence graft function after clinical islet transplantation?

Transplantation. 2018;102(11):1857–1863.

33.

Ricordi

Gray

Hering

Kaufman

Warnock

Kneteman

Lake

London

Socci

Alejandro

. Islet isolation assessment in man and large animals. Acta Diabetol Lat. 1990;27(3):185–195.

34.

Buchwald

Bernal

Echeverri

Tamayo-Garcia

Linetsky

Ricordi

. Fully automated islet cell counter (ICC) for the assessment of islet mass, purity, and size distribution by digital image analysis. Cell Transplant. 2016;25(10):1747–1761.

35.

Gmyr

Bonner

Lukowiak

Pawlowski

Dellaleau

Belaich

Aluka

Moermann

Thevenet

Ezzouaoui

Queniat

, et al. Automated digital image analysis of islet cell mass using Nikon’s inverted eclipse Ti microscope and software to improve engraftment may help to advance the therapeutic efficacy and accessibility of islet transplantation across centers. Cell Transplant. 2015;24(1):1–9.

36.

Habart

Svihlik

Schier

Cahova

Girman

Zacharovova

Berkova

Kriz

Fabryova

Kosinova

Papackova

, et al. Automated analysis of microscopic images of isolated pancreatic islets. Cell Transplant. 2016;25(12):2145–2156.

37.

Wang

Kaufman

. Digital image analysis to assess quantity and morphological quality of isolated pancreatic islets. Cell Transplant. 2016;25(7):1219–1225.

38.

Podczeck

Newton

. A shape factor to characterize the quality of spheroids. J Pharm Pharmacol. 1994;46(2):82–85.

39.

Gonzalez

Salgado

Medrano

Mullen

Komatsu

. Isolated pancreatic islet yield and quality is inversely related to organ donor age in rats. Exp Gerontol. 2019;128:110739.

40.

Orr

Stratton

Rao

Al-Sayed

Smith

El-Shahawy

Dafoe

Mullen

Al-Abdullah

Kandeel

. Quantifying insulin therapy requirements to preserve islet graft function following islet transplantation. Cell Transplant. 2016;25(1):83–95.

41.

The National Institute of Allergy and Infectious Diseases (NIAID), The National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK). Clinical islet transplantation (CIT) protocol CIT-07 islet transplantation in type 1 diabetes. [Internet]. https://repository.niddk.nih.gov/media/studies/cit-07/Protocol.pdf (2008, accessed September 1, 2021).

42.

Glieberman

Pope

Melton

Parker

. Building biomimetic potency tests for islet transplantation. Diabetes. 2021;70(2):347–363.

43.

Omori

Mullen

McFadden

Valiente

Juan

Bilbao

Tegtmeier

Dafoe

Kandeel

Al-Abdullah

. Prophylactically decontaminating human islet product for safe clinical application: effective and potent method. Transplant Direct. 2016;2(2):e63.

44.

U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research. Guidance for industry considerations for allogeneic pancreatic islet cell products. [Internet]. https://www.fda.gov/media/77497/download (2009, accessed September 1, 2021).

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.90 MB

1.55 MB

1.01 MB

A Multiparametric Assessment of Human Islets Predicts Transplant Outcomes in Diabetic Mice

Abstract

Keywords

Introduction

Materials and Methods

Study Design

Human Donor Pancreata for Islet Isolation

Isolation of Human Islets

Islet Multiparametric Assessment

Metabolic Assessment of Isolated Islets

Other Post-Isolation Assessments

Human Islet Transplantation Into Diabetic Immunodeficient Mice

Statistical Analysis

Results

Islet Characteristics and Morphological Scoring

Islet Morphological Score Strongly Correlates with in vivo Islet Transplantation Outcomes

Islet Morphological Grade is Comparable to Metabolic Assessment (OCR) as a Predictor of Transplantation Outcome

Individual Parameters in Islet Evaluation Correlate with Transplantation Outcome

Discussion

Supplemental Material

Supplemental Material, sj-jpg-1-cll-10.1177_09636897211052291 - A Multiparametric Assessment of Human Islets Predicts Transplant Outcomes in Diabetic Mice

Supplemental Material

Supplemental Material, sj-jpg-2-cll-10.1177_09636897211052291 - A Multiparametric Assessment of Human Islets Predicts Transplant Outcomes in Diabetic Mice

Supplemental Material

Supplemental Material, sj-jpg-3-cll-10.1177_09636897211052291 - A Multiparametric Assessment of Human Islets Predicts Transplant Outcomes in Diabetic Mice

Footnotes

Acknowledgments

Authorship

Disclosure

Ethical Approval

Statement of Human and Animal rights

Statement of Informed Consent

Data availability statement

Declaration of Conflicting Interests

Funding

ORCID iDs

Supplemental Material

References

Supplementary Material